Health Technology Net

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Staff August 20, 2025

Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working...

Eleos Launches AI Scanner to Navigate Medicaid Eligibility Risk in Real Time

Staff August 20, 2025

The new OBBBA AI scanner uses Eleos’ ambient AI technology to alert providers of patient eligibility changes, preserving revenue and...

Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control

Staff August 20, 2025

--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a...

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Staff August 20, 2025

WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage...

Option Care Health Announces Chief Financial Officer Transition

Staff August 20, 2025

Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1,...

Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027

Staff August 20, 2025

Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic...

Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment

Staff August 20, 2025

MANKATO, Minn., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions Inc.,...

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Staff August 20, 2025

WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage...

Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market

Staff August 20, 2025

JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today...

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Staff August 20, 2025

ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical...

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Staff August 20, 2025

With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and...

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs

Staff August 20, 2025

SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company...

Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments

Staff August 20, 2025

U.S. Senate Appropriations Report Further Validates Adial’s Therapeutic Approach and Promotes a More Contemporary Patient Focused Regulatory EnvironmentGLEN ALLEN, Va.,...

Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology

Staff August 20, 2025

Global patent estate encompasses 80 issued patents and 40 pending patent applications Strengthens strategic position in a multi-billion-dollar market opportunity...

Hemp Hop Launches 93% THCa Concentrate + 2 Exotic THCa Flowers

Staff August 20, 2025

CHARLOTTE, N.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Hemp Hop, a trusted name in premium hemp products since 2018, has...

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing

Staff August 20, 2025

FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), today clarified that a Schedule 13D...

Health Technology Net

Did You Know?

The Case for Cardiovascular Collaboration: Why Platform Partnerships Drive Greater Practice Impact

Yonsei University Researchers Develop Deep Learning Model for Microsatellite Instability-High Tumor Prediction

AI Technology Could Dramatically Lower Lung Cancer Mortality Rates

The Relationship Between CMS Star Ratings and Financial Improvement

The Future of Ultrasound Reporting

Editor’s Picks

Being a Practice Owner Doesn’t Mean Skipping Holidays—Here’s How You Can Prepare

$35 Insulin: How The Program Came To Be, Who Did It And How Can You Use It?

Qiming Venture Partners’ Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Entering the New Year, VARON Strengthens Commitment to Dependable Oxygen Support

MedMira Reports First Quarter Results FY2026

Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Eleos Launches AI Scanner to Navigate Medicaid Eligibility Risk in Real Time

Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Option Care Health Announces Chief Financial Officer Transition

Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027

Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs

Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments

Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology

Hemp Hop Launches 93% THCa Concentrate + 2 Exotic THCa Flowers

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing

Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

BBOT to Participate in Upcoming September Investor Healthcare Conferences

genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration

Qiming Venture Partners’ Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Entering the New Year, VARON Strengthens Commitment to Dependable Oxygen Support

MedMira Reports First Quarter Results FY2026

Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

Did You Know?

Editor’s Picks

Latest News

Fresh Off The press

You may have missed